show works please

Blundell Biotech. Blundell Biotech is a US-based biotechnology company with operations and earnings in a number of foreign countries. The company's profits by subsidiary, in local currency (in millions) along with the average exchange rate for each year, by currency pairs, are shown in the table for 2013 and 2014. Use these data to answer the following questions. a. What was Blundell Biotech's consolidated profits in US dollars in 2013 and 2014? b. If the same exchange rates were used for both years, which is often called a "constant currency basis" what was the change in corporato earnings on a constant currency basis? c. Using the results of the constant currency analysis in part(b). Is it possible to separate Blundell's growth in earings between local currency earnings and foreign exchange rate impacts on a consolidated basis? 09 JapaneseSul BritishSubsidi EuropeanSub ChineseSubsi RussianSubsid United StatesSub Net Income JPY GBP EUR CNY RUB USD 2013 1502 90.94 197.58 158.11 131.95 360.31 2014 1456 106.87 213.59 186.32 125.65 391.21 (b) Exchange Rate JPY = 1 USD USD = 1 GBP USD = 1 EUR CNY = 1 USD RUB = 1 USD USD 2013 97.57 1.5404 1.2743 6.2162 31.79 2014 105.83 1.6286 1.4063 6.1735 38.64 1 1 Net Income Japanese British Subsidiary Subsidiary 15.40 140.08 European Chinese Russian U.S. Subsidiary Subsidiary Subsidiary Subsidiary 25178 25.44 14.15 360.31 300 37 30 18 3.25 391 21 Consolidated Earnings 797.16 (USD) (2013 (2014) Change (%) 13.76 174.05 912.82 14.50 b. If the same exchange rates were used for both years, what was the change in corporate earnings on a "constant currency" basis? Calculate the earnings from individual subsidiaries and consolidation below: (Round to two decimal places.) Net Income (USD) (2014) Change (%) Japanese British Subsidiary Subsidiary 14.92 3.05